CDHR3 gene variation and childhood bronchiolitis

Anders Husby; Anu Pasanen; Johannes Waage; Astrid Sevelsted; Hennie Hodemaekers; Riny Janssen; Minna K. Karjalainen; Jakob Stokholm; Bo L. Chawes; Matti Korppi; Göran Wennergren; Andrea Heinzmann; Louis Bont; Hans Bisgaard; Klaus Bønnelykke

doi:10.1016/j.jaci.2017.06.044

CDHR3 gene variation and childhood bronchiolitis

Anders Husby, Anu Pasanen, Johannes Waage, Astrid Sevelsted, Hennie Hodemaekers, Riny Janssen, Minna K. Karjalainen, Jakob Stokholm, Bo L. Chawes, Matti Korppi, Göran Wennergren, Andrea Heinzmann, Louis Bont, Hans Bisgaard, Klaus Bønnelykke

Onderzoeksoutput: Bijdrage aan tijdschrift › Artikel › peer review

12 Citaten (Scopus)

Originele taal-2	Engels
Pagina's (van-tot)	1469-1471.e7
Tijdschrift	Journal of Allergy and Clinical Immunology
Volume	140
Nummer van het tijdschrift	5
DOI's	https://doi.org/10.1016/j.jaci.2017.06.044
Status	Gepubliceerd - nov. 2017
Extern gepubliceerd	Ja

Toegang tot document

10.1016/j.jaci.2017.06.044

Citeer dit

Husby, A., Pasanen, A., Waage, J., Sevelsted, A., Hodemaekers, H., Janssen, R., Karjalainen, M. K., Stokholm, J., Chawes, B. L., Korppi, M., Wennergren, G., Heinzmann, A., Bont, L., Bisgaard, H., & Bønnelykke, K. (2017). CDHR3 gene variation and childhood bronchiolitis. Journal of Allergy and Clinical Immunology, 140(5), 1469-1471.e7. https://doi.org/10.1016/j.jaci.2017.06.044

@article{a759436132e9467db95d0cbb5f52b185,

title = "CDHR3 gene variation and childhood bronchiolitis",

author = "Anders Husby and Anu Pasanen and Johannes Waage and Astrid Sevelsted and Hennie Hodemaekers and Riny Janssen and Karjalainen, {Minna K.} and Jakob Stokholm and Chawes, {Bo L.} and Matti Korppi and G{\"o}ran Wennergren and Andrea Heinzmann and Louis Bont and Hans Bisgaard and Klaus B{\o}nnelykke",

note = "Funding Information: Disclosure of potential conflict of interest: H. Bisgaard received consultancy fees from Chiesi Parmaceuticals and Boehringer-Ingelheim; his institution received grants from the Lundbeck Foundation, the Novo Nordisk Foundation, the Danish Ministry of Health, and the Danish Strategic Research Foundation as well as Danish patent no. PA 2012 00368 for other works. K. B{\o}nnelykke received consultancy fees from Alk Abello; his institution received grants from the Lundbeck Foundation, the Novo Nordisk Foundation, the Danish Ministry of Health, the Danish Strategic Research Foundation, and grant number NHLBI R01 HL129735 from the National Institutes of Health and Danish patent number PA 2012 00368. The rest of the authors declare that they have no relevant conflicts of interest. Funding Information: All funding received by COPSAC is listed on www.copsac.com . The Lundbeck Foundation (grant no. R16-A1694 ), the Ministry of Health (grant no. 903516 ), the Danish Council for Strategic Research (grant no. 0603-00280B ), and the Capital Region Research Foundation have provided core support to the COPSAC research center. ",

year = "2017",

month = nov,

doi = "10.1016/j.jaci.2017.06.044",

language = "English",

volume = "140",

pages = "1469--1471.e7",

journal = "Journal of Allergy and Clinical Immunology",

issn = "0091-6749",

publisher = "Mosby Inc.",

number = "5",

}

Husby, A, Pasanen, A, Waage, J, Sevelsted, A, Hodemaekers, H, Janssen, R, Karjalainen, MK, Stokholm, J, Chawes, BL, Korppi, M, Wennergren, G, Heinzmann, A, Bont, L, Bisgaard, H & Bønnelykke, K 2017, 'CDHR3 gene variation and childhood bronchiolitis', Journal of Allergy and Clinical Immunology, vol. 140, nr. 5, blz. 1469-1471.e7. https://doi.org/10.1016/j.jaci.2017.06.044

TY - JOUR

T1 - CDHR3 gene variation and childhood bronchiolitis

AU - Husby, Anders

AU - Pasanen, Anu

AU - Waage, Johannes

AU - Sevelsted, Astrid

AU - Hodemaekers, Hennie

AU - Janssen, Riny

AU - Karjalainen, Minna K.

AU - Stokholm, Jakob

AU - Chawes, Bo L.

AU - Korppi, Matti

AU - Wennergren, Göran

AU - Heinzmann, Andrea

AU - Bont, Louis

AU - Bisgaard, Hans

AU - Bønnelykke, Klaus

N1 - Funding Information: Disclosure of potential conflict of interest: H. Bisgaard received consultancy fees from Chiesi Parmaceuticals and Boehringer-Ingelheim; his institution received grants from the Lundbeck Foundation, the Novo Nordisk Foundation, the Danish Ministry of Health, and the Danish Strategic Research Foundation as well as Danish patent no. PA 2012 00368 for other works. K. Bønnelykke received consultancy fees from Alk Abello; his institution received grants from the Lundbeck Foundation, the Novo Nordisk Foundation, the Danish Ministry of Health, the Danish Strategic Research Foundation, and grant number NHLBI R01 HL129735 from the National Institutes of Health and Danish patent number PA 2012 00368. The rest of the authors declare that they have no relevant conflicts of interest. Funding Information: All funding received by COPSAC is listed on www.copsac.com . The Lundbeck Foundation (grant no. R16-A1694 ), the Ministry of Health (grant no. 903516 ), the Danish Council for Strategic Research (grant no. 0603-00280B ), and the Capital Region Research Foundation have provided core support to the COPSAC research center.

PY - 2017/11

Y1 - 2017/11

UR - http://www.scopus.com/inward/record.url?scp=85028516382&partnerID=8YFLogxK

U2 - 10.1016/j.jaci.2017.06.044

DO - 10.1016/j.jaci.2017.06.044

M3 - Article

C2 - 28782631

AN - SCOPUS:85028516382

SN - 0091-6749

VL - 140

SP - 1469-1471.e7

JO - Journal of Allergy and Clinical Immunology

JF - Journal of Allergy and Clinical Immunology

IS - 5

ER -